Bath & Body Works financials
$15.99−1.24%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Jan 31 | FY25 Feb 1 | FY24 Feb 3 | FY23 Jan 28 | FY22 Jan 29 |
|---|---|---|---|---|---|
| Revenue | $7.29B | $7.31B | $7.43B | $7.56B | $7.88B |
| Gross profit | $3.19B | $3.23B | $3.24B | $3.25B | $3.85B |
| Gross margin | 43.7% | 44.3% | 43.6% | 43.1% | 48.9% |
| Operating income | $1.13B | $1.27B | $1.28B | $1.38B | $2.01B |
| Net income | $649.0M | $798.0M | $878.0M | $800.0M | $1.33B |
| Net margin | 8.9% | 10.9% | 11.8% | 10.6% | 16.9% |
| Diluted EPS | $3.11 | $3.61 | $3.84 | $3.43 | $4.88 |
| EBITDA | $1.38B | $1.55B | $1.55B | $1.60B | $2.37B |
| Operating cash flow | $1.10B | $886.0M | $954.0M | $1.14B | $1.49B |
| Free cash flow | $865.0M | $660.0M | $656.0M | $816.0M | $1.22B |
| Diluted shares | 209.0M | 221.0M | 229.0M | 233.0M | 273.0M |
Balance sheet
| Period end | Jan 31 | Feb 1 | Feb 3 | Jan 28 | Jan 29 |
|---|---|---|---|---|---|
| Cash & equivalents | $953.0M | $674.0M | $1.08B | $1.23B | $1.98B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $3.89B | $3.88B | $4.39B | $4.86B | $4.85B |
| Total assets | $5.07B | $4.87B | $5.46B | $5.49B | $6.03B |
| Total liabilities | $6.35B | $6.25B | $7.09B | $7.70B | $7.54B |
| Shareholders' equity | -$1.28B | -$1.38B | -$1.63B | -$2.21B | -$1.52B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology